Intervention not reported
Death (all‐causes) · Post‐menopausal women
The intervention showed no clear difference in death (all‐causes) (high certainty).
1 finding from 1 review
Intervention not reported
Coronary heart disease (death from cardiovascular causes and non‐fatal myocardial infarction) · Post‐menopausal women
The intervention showed no clear difference in coronary heart disease (death from cardiovascular causes and… (high certainty).
1 finding from 1 review
Intervention not reported
Stroke · Post‐menopausal women
The intervention leads to higher stroke (high certainty).
1 finding from 1 review
Intervention not reported
Venous thromboembolism · Post‐menopausal women
The intervention leads to higher venous thromboembolism (high certainty).
1 finding from 1 review
All cardiovascular death · Post‐menopausal women without prior cardiovascular disease
Hormone therapy showed no clear difference in death (cardiovascular causes) compared with placebo (high certainty).
1 finding from 1 review
Stroke · Post‐menopausal women without prior cardiovascular disease
Hormone therapy leads to higher stroke compared with placebo (high certainty).
1 finding from 1 review
Venous thromboembolism · Post‐menopausal women without prior cardiovascular disease
Hormone therapy probably leads to higher venous thromboembolism compared with placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · Post‐menopausal women without prior cardiovascular disease
1 finding from 1 review
Death (all‐causes) · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in death (all‐causes) compared with placebo (high certainty).
1 finding from 1 review
All cardiovascular death · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in death (cardiovascular causes) compared with placebo (high certainty).
1 finding from 1 review
Stroke · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in stroke compared with placebo (moderate certainty).
1 finding from 1 review
Venous thromboembolism · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy leads to higher venous thromboembolism compared with placebo (high certainty).
1 finding from 1 review
Angina reduction ‐ NYHA scale Decrease in two angina classes or more · patients with refractory angina
Transmyocardial laser revascularization may leads to higher angina reduction Decrease in two angina classes or more compared with medical treatment (low certainty).
2 findings from 1 review
Angina reduction ‐ CCS score Decrease in two angina classes or more · patients with refractory angina
Transmyocardial laser revascularization may leads to higher angina reduction ‐ CCS score Decrease in two angina classes or more compared with medical treatment (low certainty).
1 finding from 1 review
Overall mortality · patients with refractory angina
Transmyocardial laser revascularization showed no clear difference in overall mortality compared with medical treatment (high certainty).
1 finding from 1 review
Early postoperative mortality Deaths in the 30 days after surgery · patients with refractory angina
Transmyocardial laser revascularization showed no clear difference in early postoperative mortality Deaths in the 30 days after surgery compared with medical treatment (high certainty).
1 finding from 1 review
Exercise tolerance Minutes · patients with refractory angina
1 finding from 1 review
Intervention not reported
Death at any time · patients with acute coronary syndrome
The intervention may leads to lower death at any time (low certainty).
1 finding from 1 review
Intervention not reported
hour Plasma Creatine Phosphokinase · patients with acute coronary syndrome
1 finding from 1 review
Intervention not reported
hour Plasma Creatine Phosphate · patients with acute coronary syndrome
1 finding from 1 review